A blocked nose is often brushed aside as a minor discomfort. However, it can trigger snoring and restless nights. Here's ...

Recently published Chronic Rhinosinusitis with Nasal Polyps Market Insights report includes a comprehensive understanding of current treatment practices, chronic rhinosinusitis with nasal polyps ...

Dupilumab yields rapid reductions in nasal polyp burden and improvements in smell function; these benefits persist with extended dosing intervals.

Tezepelumab is associated with beneficial changes in nasal polyp gene expression in patients with chronic rhinosinusitis with ...

PHILADELPHIA — The investigational drug verekitug improved sinonasal symptoms, reduced nasal polyp size, and reduced the need for nasal polyp surgery in people with chronic rhinosinusitis with nasal ...

Women using estrogen-containing contraceptives vs. not using any systemic hormonal contraceptives had reduced odds for ...

The chronic rhinosinusitis with nasal polyps market growth is being driven by rising disease prevalence, greater awareness, and improved diagnostic rates. Advancements in biologic therapies ...

Treatment with SCS is still common among patients with CRSwNP with or without comorbid asthma, despite the availability of ...

One of the most bothersome things about being sick or having seasonal allergies is that it makes your nose stuffy and blocked ...

A persistently blocked nose is more than just an inconvenience. For many people, it becomes a daily struggle that affects sleep, breathing, concentration, and overall quality of life. While occasional ...

Phase 3 LIBERTY-AIMS results showed dupilumab reduced nasal polyp size and sinus symptoms in adults and children with allergic fungal rhinosinusitis.

VIBRANT (NCT06164704) was a Phase 2 global, randomized, double-blind, placebo-controlled, parallel group clinical trial that evaluated the efficacy and safety of verekitug over 24 weeks in 81 adults ...